摘要
Cancer genomics is a rapidly growing discipline in which the genetic molecular basis of malignancy is studied at the scale of whole genomes.While the discipline has been successful with respect to identifying specific oncogenes and tumor suppressors involved in oncogenesis,it is also challenging our approach to managing patients suffering from this deadly disease.Specifically cancer genomics is driving clinical oncology to take a more molecular approach to diagnosis,prognostication,and treatment selection.We review here recent work undertaken in cancer genomics with an emphasis on translation of genomic findings.Finally,we discuss scientific challenges and research opportunities emerging from findings derived through analysis of tumors with high-depth sequencing.
Cancer genomics is a rapidly growing discipline in which the genetic molecular basis of malignancy is studied at the scale of whole genomes. While the discipline has been successful with respect to identifying specific oncogenes and tumor suppressors involved in oncogenesis, it is also challenging our approach to managing patients suffering from this deadly disease. Specifically cancer genomics is driving clinical oncology to take a more molecular approach to diagnosis, prognostication, and treatment selection. We review here recent work undertaken in cancer genomics with an emphasis on translation of genomic findings. Finally, we discuss scientific challenges and research opportunities emerging from findings derived through analysis of tumors with high-depth sequencing.
基金
supported in part by the National Institutes of Health through MD Anderson's Cancer Center Support Grant CA016672
